Search

everythinglearnresearchcommunity

for

Search:↓

Ginsenoside compound K shows promise for treating metabolic diseases like obesity and diabetes, but more research is needed on its safety and effectiveness.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

GLP-1 receptor agonists can help manage PCOS metabolism but need careful use before conception.

LGD1069 effectively prevents breast tumors in mice without toxicity.

20(S)-Protopanaxadiol-aglycone may help prevent and treat prostate cancer by reducing androgen receptor activity.

GLP-1 agonists may increase the risk of hair loss.

GLP-1 receptor analogs may help improve metabolism and reproductive health in people with PCOS and obesity.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

GLP-1 receptor agonists can cause skin reactions, facial fat loss, and hair loss, but may help with wound healing and skin conditions.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

GLP-1RA therapy may increase the risk of hair loss.

GLP-1 receptor agonists help women with PCOS lose weight and improve health, but more research is needed on long-term effects.

GLP-1 receptor agonists may cause hair loss, but regrowth is rare.

Pioglitazone combined with metformin or spironolactone improves PCOS symptoms and insulin resistance.

GLP-1 receptor agonists help with weight loss but need to be combined with other treatments for best results.

GLP-1 receptor agonists may cause hair loss, but more research is needed.

GLP-1RAs, like semaglutide and tirzepatide, may cause hair loss, so patients should be informed and monitored.

GLP1-RAs may have higher reports of suicide and hair loss, but no strong evidence links them to these issues.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

GLP-1 RAs help with diabetes and skin issues but can cause skin reactions and surgery challenges.

Some drugs linked to growth hormones may increase the chance of hair loss in women.

GLP-1 receptor agonists can both help and harm hair, so careful monitoring is needed.

GLP-1 receptor agonists may increase the risk of a specific type of hair loss called androgenetic alopecia.

Blocking glucocorticoid receptors improves glucose metabolism in a PCOS mouse model.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

Compounds from Pterocarpus indicus may help treat benign prostatic hyperplasia by stopping cell growth.

Upadacitinib effectively treats pyoderma gangrenosum.

GLP-1 receptor agonists can cause skin and hair issues due to rapid weight loss, but these can be managed with proper care and treatments.

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.